Analytical sensitivity of the LiquidHALLMARK assay.
收藏NIAID Data Ecosystem2026-03-13 收录
数据链接：
官方服务：
资源简介：
Analytical sensitivity of the LiquidHALLMARK assay.
应用场景：
创建时间：
2022-04-29
相关数据集
Mutation Scanning Using MUT-MAP, a High-Throughput, Microfluidic Chip-Based, Multi-Analyte Panel
Targeted anticancer therapies rely on the identification of patient subgroups most likely to respond to treatment. Predictive biomarkers play a key role in patient selection, while diagnostic and prog
NIAID Data Ecosystem110
Detection of KRAS, NRAS et BRAF Mutations in Plasma Circulating DNA From Patients With Metastatic Colorectal Cancer
RAS genotyping is mandatory for the prescription of anti-EGFR (epidermal growth factor receptor) therapies in patients with metastatic colorectal cancer. The standard genotyping is assessed on formali
NIAID Data Ecosystem40
Enhanced Duplex Sequencing methodology for high efficiency error suppression at variable sequencing depths
Detection of cancer-associated somatic mutations has broad applications for oncology and precision medicine. However, this becomes challenging when DNA from cancer cells is in low abundance such as in
NIAID Data Ecosystem30
Data_Sheet_1_Standardization of Sequencing Coverage Depth in NGS: Recommendation for Detection of Clonal and Subclonal Mutations in Cancer Diagnostics.pdf
The insufficient standardization of diagnostic next-generation sequencing (NGS) still limits its implementation in clinical practice, with the correct detection of mutations at low variant allele freq
NIAID Data Ecosystem40
Analytical validation of the Target Selector ctDNA platform featuring single copy detection sensitivity for clinically actionable EGFR , BRAF , and KRAS mutations
Background Personalized medicine requires accurate molecular profiling for targeted therapy decisions. Insufficient tissue yield or tumor heterogeneity frequently limits the correct tissue biomarker d
NIAID Data Ecosystem40
